Nathan J. Dowden, President & COO at Entrada Therapeutics, Inc. (TRDA), sold 53,692 shares at $16.26 ($873K) on 2024-08-16, disclosed to the SEC on 2024-08-20.
Scheduled sale ($873k) by President & COO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $16.26 | 26,595 | $432K | 49.5% |
| 2 | $16.26 | 26,595 | $432K | 49.5% |
| 3 | $16.70 | 502 | $8K | 1.0% |
| Total | $16.26 avg | 53,692 | $873K | 100% |
| Filing → |
| TRDA | SELL | 2024-09-30 | $14K | — | Filing → |
| TRDA | SELL | 2024-09-10 | $35K | — | Filing → |
| TRDA | SELL | 2024-03-08 | $22K | — | Filing → |